SCHEMBL6727796

SCHEMBL6727796

CC/C=C\C[C@@H]1C(O)CC[C@@H]1CC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.52
AKR1C3 P42330 1/20 0.52
AKR1C2 P52895 1/20 0.52
TBXA2R P21731 9/20 0.36
ALDH1A1 P00352 4/20 0.33
CYP19A1 P11511 2/20 0.33
RXRA P19793 2/20 0.33
PPARG P37231 2/20 0.33
OXER1 Q8TDS5 2/20 0.33
FFAR1 O14842 1/20 0.33
MAPT P10636 1/20 0.33
SLC6A12 P48065 3/20 0.32
SLC6A11 P48066 3/20 0.32
SLC6A13 Q9NSD5 3/20 0.32
F7 P08709 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
F3 P13726 1/20 0.31
PTGS1 P23219 1/20 0.31
KMT2A Q03164 1/20 0.31
PPARD Q03181 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669993 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL30180824 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL669994 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL18853787 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL18853799 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL29517213 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL6727788 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL18853784 0.85 AKR1C4 (0.37) AKR1C4AKR1C3AKR1C2TBXA2RSLC6A12
SCHEMBL22814915 0.84 AKR1C4 (0.43) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL22814859 0.84 AKR1C4 (0.36) AKR1C4AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040185075-A1 Use of at least one (dihydro)jasmonic acid derivative for treating dry skin L'OREAL S.A. (FR) 2004-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040185075-A1 Use of at least one (dihydro)jasmonic acid derivative for treating dry skin CUTA, ALOX15, ALOX15B AKR1C4 1048/4885AKR1C3 890/4885AKR1C2 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.